scholarly journals Pilomyxoid Astrocytoma Occurring in the Third Ventricle

2015 ◽  
Vol 5 ◽  
pp. 41
Author(s):  
Sanghyeon Kim ◽  
Myongjin Kang ◽  
Sunseob Choi ◽  
Dae Cheol Kim
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
World Health Organization ◽  
Third Ventricle ◽  
World Health ◽  
Central Nervous System Tumor ◽  
Pilomyxoid Astrocytoma ◽  
The Third ◽  
The Central Nervous System ◽  
Health Organization

Pilomyxoid astrocytoma (PMA) is a rare central nervous system tumor that has been included in the 2007 World Health Organization Classification of Tumors of the Central Nervous System. Due to its more aggressive behavior, PMA is classified as Grade II neoplasm by the World Health Organization. PMA predominantly affects the hypothalamic/chiasmatic region and occurs in children (mean age of occurrence = 10 months). We report a case of a 24-year-old man who presented with headache, nausea, and vomiting. Brain CT and MRI revealed a mass occupying only the third ventricle. We performed partial resection. Histological findings, including monophasic growth with a myxoid background, and absence of Rosenthal fibers or eosinophilic granular bodies, as well as the strong positivity for glial fibrillary acidic protein were consistent with PMA.

The 2016 World Health Organization classification of tumours of the central nervous system

2018 ◽  
Vol 47 (11-12) ◽  
pp. e187-e200 ◽  
Author(s):  
Chiara Villa ◽  
Catherine Miquel ◽  
Dominic Mosses ◽  
Michèle Bernier ◽  
Anna Luisa Di Stefano
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
World Health Organization ◽  
World Health ◽  
World Health Organization Classification ◽  
The Central Nervous System ◽  
Health Organization

scholarly journals The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2016 ◽  
Vol 131 (6) ◽  
pp. 803-820 ◽  
Author(s):  
David N. Louis ◽  
Arie Perry ◽  
Guido Reifenberger ◽  
Andreas von Deimling ◽  
Dominique Figarella-Branger ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
World Health Organization ◽  
World Health ◽  
World Health Organization Classification ◽  
System A ◽  
The Central Nervous System ◽  
Classification Of Tumors ◽  
Health Organization

scholarly journals EDITORIAL PILGRIMS INFLUX, A GLOBAL THREAT FOR CROSS-MICROBIAL RESISTANCE This editorial explains the factors impacting on the risk of cross-microbial resistance at a relatively small geographical spread. Photo by Freedigitalphotos By Syed Gillani, Syed Ata -ur-Rahman, Mohi Iqbal Mohmmad Abdul PDF THE IMPACT OF THE 2016 WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMOURS OF THE CENTRAL NERVOUS SYSTEM UPON DIAGNOSIS AND PROGNOSIS This editorial discusses about the 2016 World Health Organization (WHO) Classification of Tumours of the Central Nervous System which represents a major advance in glioma classification and diagnosis. Photo by Freedigitalphotos By Lesley Ann Cala, Peter Donald Robbins PDF RESEARCH CA 19-9 IS MORE USEFUL THAN CA 125 IN THE DIAGNOSIS OF OVARIAN MALIGNANCY, AND CAN TRULY DIFFERENTIATE THE HISTOLOGICAL SUBTYPES OF THE OVARIAN TUMOURS This study focuses on the usefulness of CA 19-9 as a diagnostic tumour marker for ovarian malignancy and is being compared with CA 125. Photo by Freedigitalphotos By Abidullah Khan, Iqbal Haider, Maimoona Ayub, Majid Khan ABSTRACT PDF A CASE CONTROL STUDY OF RISK FACTORS OF CORONARY HEART DISEASE AMONG PATIENTS ADMITTED AT TERTIARY HOSPITAL IN WESTERN INDIA

2017 ◽  
Vol 10 (05) ◽  
Author(s):  
Malay B Shah ◽  
Vihang S Mazumdar ◽  
Sangeeta V Patel ◽  
Rajendra K Baxi ◽  
Kalpita K Shringarpure
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
World Health Organization ◽  
World Health ◽  
Ca 125 ◽  
Ovarian Malignancy ◽  
Microbial Resistance ◽  
The Central Nervous System ◽  
Health Organization

scholarly journals Updates on the 2016 World Health Organization Classification of Pediatric Tumors of the Central Nervous System - a systematic review

2021 ◽  
Vol 94 (3) ◽  
pp. 282-288
Author(s):  
Maria Margareta Cosnarovici ◽  
Rodica Voichița Cosnarovici ◽  
Doina Piciu
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
World Health Organization ◽  
Treatment Options ◽  
World Health ◽  
Molecular Features ◽  
Limited Effectiveness ◽  
The Central Nervous System ◽  
Health Organization

Tumors of the central nervous system (CNS) represent the main cause of death through solid tumors in children and the second most frequent neoplasm in this patient group. The poor survival rate is due to many factors, such as the large diversity of morphological features, the particular micro-environmental characteristics of the nervous tissue, the relative rareness in relation to other childhood diseases, which leads to late diagnosis and the limited effectiveness of the available treatment options. Up until 2016, brain tumors were classified according to their histologic features. The new 2016 World Health Organization (WHO) Classification of CNS tumors incorporates molecular features, alongside the immunohistology, in order to provide a more accurate understanding of the disease. The treatment consists of surgery, radiation therapy and chemotherapy. We decided to review the literature on this pathology, in order to show the importance of the recent discoveries in this field.

Sign in / Sign up

Export Citation Format

Share Document